Cited by 314Liver Disease Diagnosis and TreatmentLiver physiology and pathologyLipid metabolism and biosynthesis

The DOI matches its Crossref record; 129 of the 129 references it cites were found in a registry or an index.

Hepatic lipid metabolism and non-alcoholic fatty liver disease

Tessari, P., Coracina, A., Cosma, A., Tiengo, A.·2009·Nutrition, Metabolism and Cardiovascular Diseases

DOI 10.1016/j.numecd.2008.12.015

Open this paper in CoChat — free account

Abstract

Non-alcoholic fatty liver disease (NAFLD) is an increasingly recognized pathology with a high prevalence and a possible evolution to its inflammatory counterpart (non-alcoholic steatohepatitis, or NASH). The pathophysiology of NAFLD and NASH has many links with the metabolic syndrome, sharing a causative factor in insulin resistance. According to a two-hit hypothesis, increased intrahepatic triglyceride accumulation (due to increased synthesis, decreased export, or both) is followed by a second step (or "hit"), which may lead to NASH. The latter likely involves oxidative stress, cytochrome P450 activation, lipid peroxidation, increased inflammatory cytokine production, activation of hepatic stellate cells and apoptosis. However, both "hits" may be caused by the same factors. The aim of this article is to overview the biochemical steps of fat regulation in the liver and the alterations occurring in the pathogenesis of NAFLD and NASH.

Integrity signals

Registry

Crossref · 10.1016/j.numecd.2008.12.015

Cites

129 of 129 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652
Nonalcoholic Fatty Liver Disease
Angulo, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011775 · Cited by 5,228
Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase
Yamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K., et al. (2002) · Nature Medicine · doi:10.1038/nm788 · Cited by 4,238
Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities
Sanyal, A. J., Campbell–Sargent, C., Mirshahi, F., Rizzo, W. B., Contos, M. J., Sterling, R. K., Luketic, V. A., Shiffman, M. L., & Clore, J. N. (2001) · Gastroenterology · doi:10.1053/gast.2001.23256 · Cited by 2,078
Molecular mediators of hepatic steatosis and liver injury
Browning, J. D., & Horton, J. D. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422422 · Cited by 1,772
Peroxisome proliferator–activated receptor α mediates the adaptive response to fasting
Kersten, S., Seydoux, J., Peters, J. M., Gonzalez, F. J., Desvergne, B., & Wahli, W. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6223 · Cited by 1,649
Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population
Szczepaniak, L. S., Nurenberg, P., Leonard, D. S., Browning, J. D., Reingold, J. S., Grundy, S. M., Hobbs, H. H., & Dobbins, R. L. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00064.2004 · Cited by 1,573
Nonalcoholic Fatty Liver Disease: Predictors of Nonalcoholic Steatohepatitis and Liver Fibrosis in the Severely Obese
Dixon, J. B., Bhathal, P. S., & O’Brien, P. E. (2001) · Gastroenterology · doi:10.1053/gast.2001.25540 · Cited by 1,369
The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice
Xu, A., Wang, Y., Keshaw, H., Xu, L. Y., Lam, K. S. L., & Cooper, G. J. S. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17797 · Cited by 1,312

Show all 128 references

Sorted by citations

Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease
Ipsen, D. H., Lykkesfeldt, J., & Tveden-Nyborg, P. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2860-6 · Cited by 1,471
Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis
Rolo, A. P., Teodoro, J. S., & Palmeira, C. M. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.10.003 · Cited by 955
Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline
Berglund, L., Brunzell, J. D., Goldberg, A. C., Goldberg, I. J., Sacks, F., Murad, M. H., & Stalenhoef, A. F. H. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3213 · Cited by 887
De novo lipogenesis in health and disease
Ameer, F., Scandiuzzi, L., Hasnain, S., Kalbacher, H., & Zaidi, N. (2014) · Metabolism · doi:10.1016/j.metabol.2014.04.003 · Cited by 650
Oxidative Stress as a Critical Factor in Nonalcoholic Fatty Liver Disease Pathogenesis
Spahis, S., DELVIN, E. E., Borys, J.-M., & Levy, E. H. (2016) · Antioxidants and Redox Signaling · doi:10.1089/ars.2016.6776 · Cited by 394
Acetaldehyde adducts in alcoholic liver disease
Setshedi, M., Wands, J. R., & de la Monte, S. M. (2010) · Oxidative Medicine and Cellular Longevity · doi:10.4161/oxim.3.3.12288 · Cited by 365
Severity of Nonalcoholic Fatty Liver Disease and Progression to Cirrhosis Are Associated With Atherogenic Lipoprotein Profile
Siddiqui, M. S., Fuchs, M. A., Idowu, M. O., Luketic, V. A., Boyett, S. L., Sargeant, C., Stravitz, R. T., Puri, P., Matherly, S. C., Sterling, R. K., et al. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.10.008 · Cited by 240
Molecular Pathogenesis of NASH
Caligiuri, A., Gentilini, A., & Marra, F. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17091575 · Cited by 219
Experimental models of non-alcoholic fatty liver disease in rats
Kučera, O. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i26.8364 · Cited by 194
PGC-1α overexpression results in increased hepatic fatty acid oxidation with reduced triacylglycerol accumulation and secretion
Morris, E. M., Meers, G. M.-E., Booth, F. W., Fritsche, K. L., Hardin, C. D., Thyfault, J. P., & Ibdah, J. A. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00169.2012 · Cited by 186
Difference in expression of hepatic microRNAs miR-29c, miR-34a, miR-155, and miR-200b is associated with strain-specific susceptibility to dietary nonalcoholic steatohepatitis in mice
Pogribny, I. P., Starlard‐Davenport, A., Tryndyak, V., Han, T., Ross, S. A., Rusyn, I., & Beland, F. A. (2010) · Laboratory Investigation · doi:10.1038/labinvest.2010.113 · Cited by 185
Zonation of glucose and fatty acid metabolism in the liver: Mechanism and metabolic consequences
Hijmans, B. S., Grefhorst, A., Oosterveer, M. H., & Groen, A. K. (2013) · Biochimie · doi:10.1016/j.biochi.2013.06.007 · Cited by 184
Hydrogen sulfide and the liver
Mani, S., Cao, W., Wu, L., & Wang, R. (2014) · Nitric Oxide · doi:10.1016/j.niox.2014.02.006 · Cited by 157
Betulinic acid alleviates non-alcoholic fatty liver by inhibiting SREBP1 activity via the AMPK–mTOR–SREBP signaling pathway
Quan, H. Y., Kim, D. Y., Kim, S. J., Jo, H. K., Kim, G. W., & Chung, S. H. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.02.007 · Cited by 156
Nonalcoholic fatty liver disease is associated with lower hepatic and erythrocyte ratios of phosphatidylcholine to phosphatidylethanolamine
Arendt, B. M., David, W. L., Simons, B. L., Noureldin, S. A., Therapondos, G., Guindi, M. M., Sherman, M., & Allard, J. P. (2013) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2012-0261 · Cited by 154
Therapeutic Role of Ursolic Acid on Ameliorating Hepatic Steatosis and Improving Metabolic Disorders in High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease Rats
Li, S., Meng, F., Liao, X.-L., Wang, Y., Sun, Z., Guo, F., Li, X., Meng, M., Li, Y., & Sun, C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086724 · Cited by 155
Sympathetic nervous system control of triglyceride metabolism: novel concepts derived from recent studies
Geerling, J. J., Boon, M. R., Kooijman, S., Parlevliet, E. T., Havekes, L. M., Romijn, J. A., Meurs, I. M., & Rensen, P. C. N. (2014) · Journal of Lipid Research · doi:10.1194/jlr.r045013 · Cited by 137
Flaxseed lignan lowers blood cholesterol and decreases liver disease risk factors in moderately hypercholesterolemic men
Fukumitsu, S., Aida, K., Shimizu, H., & Toyoda, K. (2010) · Nutrition Research · doi:10.1016/j.nutres.2010.06.004 · Cited by 128
Ginsenoside Rb1 reduces fatty liver by activating AMP-activated protein kinase in obese rats
Shen, L., Xiong, Y., Wang, D. Q. ‐., Howles, P. N., Basford, J. E., Wang, J., Xiong, Y., Hui, D. Y., Woods, S. C., & Liu, M. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m035907 · Cited by 126
Potential Therapeutic Application of Estrogen in Gender Disparity of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
Lee, C., Kim, J., & Jung, Y. (2019) · Cells · doi:10.3390/cells8101259 · Cited by 128
Differential Roles of Cell Death-inducing DNA Fragmentation Factor-α-like Effector (CIDE) Proteins in Promoting Lipid Droplet Fusion and Growth in Subpopulations of Hepatocytes
Xu, W., Wu, L., Yu, M., Chen, F., Arshad, M., Xia, X., Hao, R., Yu, J., Xu, L. M., Xu, D., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.701094 · Cited by 119
Fatty Acids - Induced Lipotoxicity and Inflammation
Savary, S., Trompier, D., Andreoletti, P., Le Borgne, F., Demarquoy, J., & Lizard, G. (2012) · Current Drug Metabolism · doi:10.2174/138920012803762729 · Cited by 111
Dendrobium officinale polysaccharide ameliorates the liver metabolism disorders of type II diabetic rats
Yang, J., Chen, H., Nie, Q., Huang, X., & Nie, S. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.08.007 · Cited by 109
Astaxanthin restricts weight gain, promotes insulin sensitivity and curtails fatty liver disease in mice fed a obesity-promoting diet
Bhuvaneswari, S., Elumalai, A., Viswanathan, P., & Anuradha, C. V. (2010) · Process Biochemistry · doi:10.1016/j.procbio.2010.05.016 · Cited by 107
Non-alcoholic fatty liver disease and metabolic syndrome in adolescents: Pathogenetic role of genetic background and intrauterine environment
Alisi, A., Cianfarani, S., Manco, M., Agostoni, C. V., & Nobili, V. (2011) · Annals of Medicine · doi:10.3109/07853890.2010.547869 · Cited by 108
Glycyrrhizin Alleviates Nonalcoholic Steatohepatitis via Modulating Bile Acids and Meta-Inflammation
Yan, T., Wang, H., Cao, L.-J., Wang, Q., Takahashi, S., Yagai, T., Li, G.-L., Krausz, K., Wang, G.-J., Gonzalez, F., et al. (2018) · Drug Metabolism And Disposition · doi:10.1124/dmd.118.082008 · Cited by 98
Dietary d-limonene alleviates insulin resistance and oxidative stress–induced liver injury in high-fat diet and L-NAME-treated rats
Santiago, J. V. A., Jayaraman, J., Shenbagam, M., & Nalini, N. (2011) · European Journal of Nutrition · doi:10.1007/s00394-011-0182-7 · Cited by 104
Non-alcoholic Fatty Liver Disease in Lean Subjects: Characteristics and Implications
Kumar, R. K., & Mohan, S. (2017) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2016.00068 · Cited by 104
Associations between fatty acid oxidation, hepatic mitochondrial function, and plasma acylcarnitine levels in mice
Bjørndal, B., Alterås, E. K., Lindquist, C., Svardal, A. M., Skorve, J., & Berge, R. K. (2018) · Nutrition & Metabolism · doi:10.1186/s12986-018-0241-7 · Cited by 100
Prebiotic approach alleviates hepatic steatosis: Implication of fatty acid oxidative and cholesterol synthesis pathways
Pachikian, B. D., Essaghir, A., Demoulin, J., Catry, É., Neyrinck, A. M., Dewulf, E. M., Sohet, F. M., Portois, L., Clerbaux, L., Carpentier, Y., et al. (2012) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201200364 · Cited by 99
Brown Alga Ecklonia cava Polyphenol Extract Ameliorates Hepatic Lipogenesis, Oxidative Stress, and Inflammation by Activation of AMPK and SIRT1 in High-Fat Diet-Induced Obese Mice
Eo, H., Jeon, Y., Lee, M., & Lim, Y. (2014) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf502830b · Cited by 99
Vanillic acid attenuates obesity via activation of the AMPK pathway and thermogenic factors in vivo and in vitro
Jung, Y., Park, J., Kim, H., Sim, J., Youn, D., Kang, J., Lim, S., Jeong, M., Yang, W. M., Lee, S., et al. (2017) · The FASEB Journal · doi:10.1096/fj.201700231rr · Cited by 91
High fat diet-induced non alcoholic fatty liver disease in rats is associated with hyperhomocysteinemia caused by down regulation of the transsulphuration pathway
Bravo, E., Palleschi, S., Aspichueta, P., Buqué, X., Rossi, B., Cano, A., Napolitano, M., Ochoa, B., & Botham, K. M. (2011) · Lipids in Health and Disease · doi:10.1186/1476-511x-10-60 · Cited by 91
In situ visualization of peroxisomal viscosity in the liver of mice with non-alcoholic fatty liver disease by near-infrared fluorescence and photoacoustic imaging
Zhou, Y., Li, P., Wang, X., Wu, C., Fan, N., Liu, X., Wu, L., Zhang, W., Zhang, W., Liu, Z., et al. (2020) · Chemical Science · doi:10.1039/d0sc02922j · Cited by 88
Multifactorial Basis and Therapeutic Strategies in Metabolism-Related Diseases
Guerra, J. V. D. S., Dias, M. M. G., Brilhante, A. J. V. C., Terra, M. F., García‐Arévalo, M., & Figueira, A. C. M. (2021) · Nutrients · doi:10.3390/nu13082830 · Cited by 92
Serum homocysteine levels, oxidative stress and cardiovascular risk in non-alcoholic steatohepatitis
Leach, N. V., Dronca, E., Vesa, Ș. C., Sâmpelean, D., Crăciun, E. C., Lupșor‐Platon, M., Crișan, D., Tarau, R., Rusu, R., Para, I., et al. (2014) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2014.09.007 · Cited by 83
Effect of aerobic exercise training on non-alcoholic fatty liver disease induced by a high fat diet in C57BL/6 mice
Cho, J., Lee, I., Kim, D.-H., Koh, Y., Kong, J., Lee, S. S., & Kang, H. (2014) · Physical Activity and Nutrition · doi:10.5717/jenb.2014.18.4.339 · Cited by 83
Osteocalcin improves nonalcoholic fatty liver disease in mice through activation of Nrf2 and inhibition of JNK
Du, J., Zhang, M., Lu, J., Zhang, X., Xiong, Q., Xu, Y., Bao, Y., & Jia, W. (2016) · Endocrine · doi:10.1007/s12020-016-0926-5 · Cited by 84
Apple peel polyphenols reduce mitochondrial dysfunction in mice with DSS-induced ulcerative colitis
Yeganeh, P. R., Leahy, J., Spahis, S., Patey, N., Desjardins, Y., Roy, D., DELVIN, E. E., Garofalo, C., Leduc‐Gaudet, J., St-Pierre, D., et al. (2018) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2018.03.008 · Cited by 85
Pediatric non-alcoholic fatty liver disease: Preventive andtherapeutic value of lifestyle intervention
Nobili, V., Alisi, A., & Raponi, M. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.6017 · Cited by 80
From chronic overfeeding to hepatic injury: Role of endoplasmic reticulum stress and inflammation
Mollica, M. P., Lionetti, L., Putti, R., Cavaliere, G., Gaita, M., & Barletta, A. (2011) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2010.10.012 · Cited by 81
Hypoxia aggravates non-alcoholic steatohepatitis in mice lacking hepatocellular PTEN
Piguet, A., Stroka, D., Zimmermann, A., & Dufour, J. (2009) · Clinical Science · doi:10.1042/cs20090313 · Cited by 79
Protective effects of Ginkgo biloba leaf polysaccharide on nonalcoholic fatty liver disease and its mechanisms
Yan, Z., Fan, R., Yin, S., Zhao, X., Liu, J., Li, L., Zhang, W., & Ge, L. (2015) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2015.05.054 · Cited by 79
Beneficial effects of rosuvastatin on insulin resistance, adiposity, inflammatory markers and non-alcoholic fatty liver disease in mice fed on a high-fat diet
Fraulob, J. C., Souza‐Mello, V., Águila, M. B., & Mandarim‐de‐Lacerda, C. A. (2012) · Clinical Science · doi:10.1042/cs20110373 · Cited by 76
Activation of the aryl hydrocarbon receptor induces hepatic steatosis via the upregulation of fatty acid transport
Kawano, Y., Nishiumi, S., Tanaka, S., Nobutani, K., Miki, A., Yano, Y., Seo, Y., Kutsumi, H., Ashida, H., Azuma, T., et al. (2010) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2010.09.001 · Cited by 74
The Lactobacillus as a Probiotic: Focusing on Liver Diseases
Jeong, J., Park, H., Cha, M. G., Park, E., Won, S., Ganesan, R., Gupta, H., Gebru, Y. A., Sharma, S. P., Lee, S. B., et al. (2022) · Microorganisms · doi:10.3390/microorganisms10020288 · Cited by 75
Thymoquinone alleviates nonalcoholic fatty liver disease in rats via suppression of oxidative stress, inflammation, apoptosis
Awad, A. S., Haleem, E. N. A. A., El‐Bakly, W. M., & Sherief, M. A. (2016) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-015-1207-1 · Cited by 76
Alisol A 24-Acetate Prevents Hepatic Steatosis and Metabolic Disorders in HepG2 Cells
Zeng, L., Tang, W., Yin, J., Feng, L., Li, Y., Yao, X., & Zhou, B. (2016) · Cellular Physiology and Biochemistry · doi:10.1159/000452560 · Cited by 73
Cherry Anthocyanins Regulate NAFLD by Promoting Autophagy Pathway
Chu, Q., Zhang, S., Chen, M., Han, W., Jia, R., Chen, W., & Zheng, X. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/4825949 · Cited by 72
Effect of methionine‐deficient and methionine‐supplemented diets on the hepatic one‐carbon and lipid metabolism in mice
Aissa, A. F., Tryndyak, V., de Conti, A., Melnyk, S., Gomes, T. D. U. H., Bianchi, M. L. P., James, S. J., Beland, F. A., Antunes, L. M. G., & Pogribny, I. P. (2014) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201300726 · Cited by 67
Resveratrol Helps Recovery from Fatty Liver and Protects against Hepatocellular Carcinoma Induced by Hepatitis B Virus X Protein in a Mouse Model
Lin, H., Chen, Y., Hsu, W., Yang, C.-W., Kao, C., & Tsai, T. (2012) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-12-0001 · Cited by 66
Ursodeoxycholic Acid Ameliorates Fructose-Induced Metabolic Syndrome in Rats
Mahmoud, A. A. A., & Elshazly, S. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106993 · Cited by 66
The Positive Effects of Grifola frondosa Heteropolysaccharide on NAFLD and Regulation of the Gut Microbiota
Li, X., Zeng, F., Huang, Y., & Liu, B. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215302 · Cited by 64
Potential role of bioactive compounds of Phaseolus vulgaris L. on lipid-lowering mechanisms
Ramírez‐Jiménez, A. K., Reynoso‐Camacho, R., Tejero, M. E., León‐Galván, M. F., & Loarca-Piña, G. F. (2015) · Food Research International · doi:10.1016/j.foodres.2015.01.002 · Cited by 65
The Impacts of Herbal Medicines and Natural Products on Regulating the Hepatic Lipid Metabolism
Li, S., Xu, Y., Guo, W., Chen, F., Zhang, C., Tan, H. Y., Wang, N., & Feng, Y. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00351 · Cited by 67
Effects of taurine on growth performance, antioxidant capacity, and lipid metabolism in broiler chickens
Han, H., Zhang, J., Yan, E., Shen, M., Wu, J., Gan, Z., Wei, C., Zhang, L. L., & Wang, T. (2020) · Poultry Science · doi:10.1016/j.psj.2020.07.020 · Cited by 67
Mechanisms of Disease Progression in NASH
Bohinc, B. N., & Diehl, A. M. (2012) · Clinics in Liver Disease · doi:10.1016/j.cld.2012.05.002 · Cited by 64
Long-term bisphenol S exposure induces fat accumulation in liver of adult male zebrafish (Danio rerio) and slows yolk lipid consumption in F1 offspring
Wang, W., Zhang, X., Qin, J., Wei, P., Jia, Y., Wang, J., & Ru, S. (2019) · Chemosphere · doi:10.1016/j.chemosphere.2019.01.020 · Cited by 62
Suboptimal maternal nutrition, during early fetal liver development, promotes lipid accumulation in the liver of obese offspring
Hyatt, M. A., Gardner, D. S., Sebert, S. P., Wilson, V., Davidson, N. J., Nigmatullina, Y., Chan, L. L. Y., Budge, H., & Symonds, M. E. (2010) · Reproduction · doi:10.1530/rep-10-0325 · Cited by 61
Mulberry extract inhibits oleic acid‐induced lipid accumulation via reduction of lipogenesis and promotion of hepatic lipid clearance
Ou, T., Hsu, M., Chan, K., Huang, C., Ho, H.-H., & Wang, C. (2011) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.4489 · Cited by 61
Scutellarin Prevents Nonalcoholic Fatty Liver Disease (NAFLD) and Hyperlipidemia via PI3K/AKT-Dependent Activation of Nuclear Factor (Erythroid-Derived 2)-Like 2 (Nrf2) in Rats
Fan, H., Ma, X., Lin, P., Kang, Q., Zhao, Z., Wang, L., Sun, D., Cheng, J., & Li, Y. (2017) · Medical Science Monitor · doi:10.12659/msm.907530 · Cited by 61
Nonalcoholic fatty liver and metabolic syndrome in Italy: results from a multicentric study of the Italian Arteriosclerosis society
Soresi, M., Noto, D., Cefalù, A., Martini, S., Vigna, G., Fonda, M., Manzato, E., Cattin, L., Fellin, R., Averna, M., et al. (2013) · Acta Diabetologica · doi:10.1007/s00592-012-0406-1 · Cited by 53
Resveratrol Attenuates High-Fat Diet Induced Hepatic Lipid Homeostasis Disorder and Decreases m6A RNA Methylation
Wu, J., Li, Y., Yu, J., Gan, Z., Wei, W., Wang, C., Zhang, L., Wang, T. Z., & Zhong, X. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.568006 · Cited by 60
Jaboticaba berry peel intake increases short chain fatty acids production and prevent hepatic steatosis in mice fed high-fat diet
Batista, Â. G., da Silva-Maia, J. K., Mendonça, M. C. P., Soares, E. S., Lima, G. C., Bogusz, S., da Cruz‐Höfling, M. A., & Maróstica, M. R. (2018) · Journal of Functional Foods · doi:10.1016/j.jff.2018.07.020 · Cited by 61
Carnosic acid (CA) prevents lipid accumulation in hepatocytes through the EGFR/MAPK pathway
Wang, T., Takikawa, Y., Tabuchi, T., Satoh, T., Kosaka, K., & Suzuki, K. (2012) · Journal of Gastroenterology · doi:10.1007/s00535-012-0546-7 · Cited by 58
Levels of Serum Ceruloplasmin Associate With Pediatric Nonalcoholic Fatty Liver Disease
Nobili, V., Siotto, M., Bedogni, G., Ravà, L., Pietrobattista, A., Panera, N., Alisi, A., & Squitti, R. (2012) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e31827aced4 · Cited by 61
Effects of Antioxidants in Reducing Accumulation of Fat in Hepatocyte
Yang, J., Shin, J., Seo, S., Kim, S., Lee, S. H., & Shin, E. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092563 · Cited by 56
Schisandrin B: A Double‐Edged Sword in Nonalcoholic Fatty Liver Disease
Leong, P. K., & Ko, K. M. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/6171658 · Cited by 56
Antioxidant effects of Se-glutathione peroxidase in alcoholic liver disease
Shen, Y., Huang, H., Wang, Y., Yang, R., & Ke, X. (2022) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2022.127048 · Cited by 56
Reduction of liver fructokinase expression and improved hepatic inflammation and metabolism in liquid fructose-fed rats after atorvastatin treatment
Vilà, L., Rebollo, A., Ađalsteisson, G. S., Alegret, M., Merlos, M., Roglans, N., & Laguna, J. C. (2010) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2010.11.011 · Cited by 55
High prevalence of diabetes mellitus in patients with liver cirrhosis
Wlazlo, N., Beijers, H. J. B. H., Schoon, E. J., Sauerwein, H. P., Stehouwer, C. D. A., & Bravenboer, B. (2010) · Diabetic Medicine · doi:10.1111/j.1464-5491.2010.03093.x · Cited by 54
Antidiabetic effects of different polysaccharide fractions from Artemisia sphaerocephala Krasch seeds in db/db mice
Li, J., Zhao, H., Hu, X., Shi, J., Shao, D., & Jin, M. (2019) · Food Hydrocolloids · doi:10.1016/j.foodhyd.2019.01.002 · Cited by 54
Chronic exposure to tetrabromodiphenyl ether (BDE-47) aggravates hepatic steatosis and liver fibrosis in diet-induced obese mice
Yang, C., Zhu, L., Kang, Q., Lee, H. K., Li, D., Chung, A. C. K., & Cai, Z. (2019) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2019.120766 · Cited by 55
Activation of Male Liver Chromatin Accessibility and STAT5-Dependent Gene Transcription by Plasma Growth Hormone Pulses
Connerney, J., Lau-Corona, D., Rampersaud, A., & Waxman, D. J. (2017) · Endocrinology · doi:10.1210/en.2017-00060 · Cited by 52
Complexity of microRNA function and the role of isomiRs in lipid homeostasis
Vickers, K. C., Sethupathy, P., Baran‐Gale, J., & Remaley, A. T. (2013) · Journal of Lipid Research · doi:10.1194/jlr.r034801 · Cited by 53
The prevalence of non-alcoholic fatty liver disease and metabolic syndrome in obese children
Gupta, R., Bhangoo, A., Matthews, N., Anhalt, H., Matta, Y., Lamichhane, B., Malik, S., Narwal, S., Wetzler, G., & Ten, S. (2011) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2011.282 · Cited by 51
Lipid biomarkers and metabolic effects of lycopene from tomato juice on liver of rats with induced hepatic steatosis
Bernal, C., Martín‐Pozuelo, G., Lozano, A. B., Sevilla, A., García‐Alonso, J., Cánovas, M., & Periago, M. J. (2013) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2013.05.003 · Cited by 53
Treatment options for hypertriglyceridemia: From risk reduction to pancreatitis
Berglund, L., Brunzell, J. D., Goldberg, A. C., Goldberg, I. J., & Stalenhoef, A. (2014) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2013.10.002 · Cited by 50
Adzuki bean ameliorates hepatic lipogenesis and proinflammatory mediator expression in mice fed a high-cholesterol and high-fat diet to induce nonalcoholic fatty liver disease
Kim, S., Hong, J., Jeon, R., & Kim, H.-S. (2015) · Nutrition Research · doi:10.1016/j.nutres.2015.11.002 · Cited by 50
Normal weight dyslipidemia: Is it all about the liver?
Ipsen, D. H., Tveden‐Nyborg, P., & Lykkesfeldt, J. (2016) · Obesity · doi:10.1002/oby.21443 · Cited by 51
Untargeted metabonomics reveals intervention effects of chicory polysaccharide in a rat model of non-alcoholic fatty liver disease
Zhu, H., Wang, Z., Wu, Y., Jiang, H., Zhou, F., Xie, X., Wang, R., & Hua, C. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.01.141 · Cited by 50
HIV protease inhibitors and obesity
Anuurad, E., Bremer, A. A., & Berglund, L. (2010) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e32833dde87 · Cited by 50
Interaction between metformin and leucine in reducing hyperlipidemia and hepatic lipid accumulation in diet-induced obese mice
Fu, L., Bruckbauer, A., Li, F., Cao, Q., Cui, X., Wu, R., Shi, H., Zemel, M. B., & Xue, B. (2015) · Metabolism · doi:10.1016/j.metabol.2015.07.006 · Cited by 49
Seed oil of Rosa roxburghii Tratt against non-alcoholic fatty liver disease in vivo and in vitro through PPARα/PGC-1α-mediated mitochondrial oxidative metabolism
Ni, H.-Y., Yu, L., Zhao, X., Wang, L., Zhao, C., Huang, H. F., Zhu, H.-L., Efferth, T., Gu, C., & Fu, Y. (2022) · Phytomedicine · doi:10.1016/j.phymed.2021.153919 · Cited by 51
Nonalcoholic Fatty Liver in Children and Adolescents: An Overview
Corte, C. D., Alisi, A., Saccari, A., Vito, R. D., Vania, A., & Nobili, V. (2012) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2012.01.010 · Cited by 48
A theoretical study of lipid accumulation in the liver—implications for nonalcoholic fatty liver disease
Schleicher, J., Guthke, R., Dahmen, U., Dirsch, O., Holzhütter, H., & Schuster, S. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2013.08.016 · Cited by 48
The effects of chronic AMPK activation on hepatic triglyceride accumulation and glycerol 3-phosphate acyltransferase activity with high fat feeding
Henriksen, B. S., Curtis, M. E., Fillmore, N., Cardon, B. R., Thomson, D. M., & Hancock, C. R. (2013) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-5-29 · Cited by 49
Cordycepin attenuates high-fat diet-induced non-alcoholic fatty liver disease via down-regulation of lipid metabolism and inflammatory responses
Gong, X., Tian-ju, L., Wan, R., & Sha, L. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.107173 · Cited by 48
Developmental origins of health and disease: experimental and human evidence of fetal programming for metabolic syndrome
Correia, M. L., Volpato, A. M., Águila, M. B., & Mandarim‐de‐Lacerda, C. A. (2011) · Journal of Human Hypertension · doi:10.1038/jhh.2011.61 · Cited by 51
Silybum marianum oil attenuates hepatic steatosis and oxidative stress in high fat diet-fed mice
Zhu, S. Y., Jiang, N., Yang, J., Tu, J., Zhou, Y. H., Xiao, X., & Dong, Y. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.01.144 · Cited by 47
Thyroid hormone analogues and derivatives: Actions in fatty liver
Coppola, M. (2014) · World Journal of Hepatology · doi:10.4254/wjh.v6.i3.114 · Cited by 47
Association between metabolic abnormalities and HBV related hepatocelluar carcinoma in Chinese: A cross-sectional study
Zhao, J., Zhao, Y., Wang, H., Gu, X., Ji, J., & Gao, C. (2011) · Nutrition Journal · doi:10.1186/1475-2891-10-49 · Cited by 46
A polyphenol extract modifies quantity but not quality of liver fatty acid content in high-fat–high-sucrose diet-fed rats: possible implication of the sirtuin pathway
Aoun, M., Michel, F., Fouret, G., Casas, F., Jullien, M., Wrutniak‐Cabello, C., Ramos, J., Cristol, J., Coudray, C., Carbonneau, M., et al. (2010) · British Journal Of Nutrition · doi:10.1017/s0007114510002850 · Cited by 48
The Potential Role of Iron and Copper in Pediatric Obesity and Nonalcoholic Fatty Liver Disease
Feldman, A., Aigner, E. S., Weghuber, D., & Paulmichl, K. (2015) · BioMed Research International · doi:10.1155/2015/287401 · Cited by 45
The Role of Liver Zonation in Physiology, Regeneration, and Disease
Panday, R., Monckton, C. P., & Khetani, S. R. (2022) · Seminars in Liver Disease · doi:10.1055/s-0041-1742279 · Cited by 47
Circadian Rhythms in Liver Physiology and Liver Diseases
Tong, X., & Yin, L. (2013) · Comprehensive physiology · doi:10.1002/cphy.c120017 · Cited by 50
Way back for fructose and liver metabolism: Bench side to molecular insights
Rebollo, A. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i45.6552 · Cited by 44
Immunohistochemical study of the autophagy marker microtubule‐associated protein 1 light chain 3 in normal and steatotic human livers
Kashima, J., Shintani‐Ishida, K., Nakajima, M., Maeda, H., Unuma, K., Uchiyama, Y., & Yoshida, K. (2013) · Hepatology Research · doi:10.1111/hepr.12183 · Cited by 43
Dyslipidemia: Obese or Not Obese—That Is Not the Question
Ipsen, D. H., Tveden‐Nyborg, P., & Lykkesfeldt, J. (2016) · Current Obesity Reports · doi:10.1007/s13679-016-0232-9 · Cited by 43
Coumarin attenuates hepatic steatosis by down-regulating lipogenic gene expression in mice fed a high-fat diet
Um, M. Y., Moon, M. K., Ahn, J., & Ha, T. Y. (2013) · British Journal Of Nutrition · doi:10.1017/s0007114512005260 · Cited by 42

Authors: Tessari, P., Coracina, A., Cosma, A., & Tiengo, A.
Affiliations: University of Padua (IT)
Corresponding author: Tessari, P.
ORCID: Tessari, P.
Venue: Nutrition, Metabolism and Cardiovascular Diseases
Publisher: Elsevier BV
Published: 2009-05
Volume: 19
Issue: 4
Pages: 291-302
ISSN: 0939-4753 (ISSN-L)
DOI: 10.1016/j.numecd.2008.12.015
OpenAlex: W1978723895
Cited by: 314
References: 128
Citations by year: 2026: 4 · 2025: 5 · 2024: 21 · 2023: 10 · 2022: 18 · 2021: 17 · 2020: 19 · 2019: 14 · 2018: 25 · 2017: 15 · 2016: 24 · 2015: 17 · 2014: 28 · 2013: 24 · 2012: 27
FWCI: 2.91
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Nutrition Metabolism and Cardiovascular Diseases (publishedVersion)
PubMed (publishedVersion)
Padua Research Archive (University of Padova) (submittedVersion)
Topics: Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
Health Sciences › Medicine › Hepatology › Liver physiology and pathology
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
Keywords: non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, hepatic lipid metabolism, insulin resistance, metabolic syndrome, two-hit hypothesis, oxidative stress, cytochrome P450 activation, lipid peroxidation, hepatic stellate cells, inflammation, apoptosis, inflammatory cytokines
MeSH terms: Animals, Diet, Fatty Acids, Fatty Liver, Humans, Lipolysis, Lipoproteins, Liver, Oxidation-Reduction, Signal Transduction, Lipogenesis, Lipid Metabolism, Adipokines, AMP-Activated Protein Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Hepatic lipid metabolism and non-alcoholic fatty liver disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks